Technical Analysis for SBM - Sirona Biochem Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% |
| Alert | Time |
|---|---|
| 3x Volume Pace | 4 days ago |
| 2x Volume Pace | 4 days ago |
| 1.5x Volume Pace | 4 days ago |
| 5x Volume Pace | 5 days ago |
| 3x Volume Pace | 5 days ago |
Get this analysis on your stocks daily!
- Earnings date: 2024-06-27
Sirona Biochem Corp. Description
Sirona Biochem Corp. is a Canada-based development-stage cosmetic ingredient and drug discovery company with a technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. It is engaged in the development of cosmetic and pharmaceutical active ingredients, which are licensed to its partners. The Company has six product lines: SGLT2 Inhibitor, Skin Lightener I, GlycoProteMin-Anti aging, Anti-inflammatory, Anti-infective and Skin Lightener II. Its development is focused on three programs: therapeutics, which includes diabetes, anti-inflammatories and anti-infectives; cosmeceuticals, which includes anti-aging and depigmenting agents (skin lighteners), and biological ingredients, which includes inducers and adjuvants for biological development and preservation. The Company, through TFChem S.A.R.L. (TFC), is engaged in using fluorine atom properties to develop glycomimetic compounds.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharma Light Pharmaceutical Drug Labor Skin Health Sciences Diabetes Pharmaceutical Industry Biological Anti Infectives Cosmetics Drug Discovery
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.215 |
| 52 Week Low | 0.055 |
| Average Volume | 49,893 |
| 200-Day Moving Average | 0.097 |
| 50-Day Moving Average | 0.069 |
| 20-Day Moving Average | 0.064 |
| 10-Day Moving Average | 0.064 |
| Average True Range | 0.004 |
| RSI (14) | 47.37 |
| ADX | 19.49 |
| +DI | 28.571 |
| -DI | 41.051 |
| Chandelier Exit (Long, 3 ATRs) | 0.057 |
| Chandelier Exit (Short, 3 ATRs) | 0.068 |
| Upper Bollinger Bands | 0.071 |
| Lower Bollinger Band | 0.056 |
| Percent B (%b) | 0.28 |
| BandWidth | 24.567 |
| MACD Line | -0.003 |
| MACD Signal Line | -0.002 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.060 | ||||
| Resistance 3 (R3) | 0.060 | 0.060 | 0.060 | ||
| Resistance 2 (R2) | 0.060 | 0.060 | 0.060 | 0.060 | |
| Resistance 1 (R1) | 0.060 | 0.060 | 0.060 | 0.060 | 0.060 |
| Pivot Point | 0.060 | 0.060 | 0.060 | 0.060 | 0.060 |
| Support 1 (S1) | 0.060 | 0.060 | 0.060 | 0.060 | 0.060 |
| Support 2 (S2) | 0.060 | 0.060 | 0.060 | 0.060 | |
| Support 3 (S3) | 0.060 | 0.060 | 0.060 | ||
| Support 4 (S4) | 0.060 |
